Picture of Sichuan Kelun-Biotech Biopharmaceutical logo

6990 — Sichuan Kelun-Biotech Biopharmaceutical News Story

0.000.00%
hk flag iconLast trade - 00:00
HealthcareSpeculativeLarge CapHigh Flyer

Brief: Sichuan Kelun-Biotech Biopharmaceutical Says Key Product A400 (Ep0031) Cleared To Start Phase 2 By US FDA

May 3 (Reuters) - Sichuan Kelun-Biotech
Biopharmaceutical  6990.HK :
    * KEY PRODUCT A400 (EP0031) CLEARED TO START PHASE 2 BY US
FDA

Further company coverage:  6990.HK 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Sichuan Kelun-Biotech Biopharmaceutical

See all news